GlassScriptPhysician profile
Jeanne B Earle
NPI 1346291457
$1,290.09
in general payments reported to CMS, 2019-2025
8 companies · $374 in 2025
The $374 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $99.92 · 2023: $340 · 2024: $476 · 2025: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,190.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $479.17 | 2022-2025 | Yeztugo, Epclusa, Descovy |
| Madrigal Pharmaceuticals | $149.56 | 2024 | Rezdiffra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.93 | 2024 | Jardiance |
| Phathom Pharmaceuticals, INC. | $117.84 | 2025 | Voquezna |
| Abbvie INC. | $114.86 | 2024 | |
| Merck Sharp & Dohme LLC | $112.07 | 2023 | Verquvo |
| Mylan Specialty L.P. | $105.01 | 2023 | Yupelri |
| Alkermes, INC. | $89.65 | 2024 | Vivitrol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeanne Earle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.